Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/OTLC/Shareholders’ equity

Oncotelic Therapeutics, Inc. (OTLC) Shareholders’ equity 2021–2024

Oncotelic Therapeutics, Inc. (OTLC) shareholders’ equity at each fiscal year-end, per SEC filings.

$12.1MFY2024 · since FY2021: $11.8M → $12.1M
2124
Fiscal yearValueYoY
FY2024$12.1M—
FY2021$11.8M—

Source: SEC XBRL filings · For reference only · Not investment advice

More OTLC financial trends

OTLC RevenueOTLC Net incomeOTLC Net marginOTLC Gross profitOTLC Gross marginOTLC Operating incomeOTLC Operating marginOTLC Operating cash flowOTLC Free cash flowOTLC Capital expendituresOTLC Return on equityOTLC Stock buybacksOTLC Dividends paidOTLC Total assetsOTLC Total liabilitiesOTLC overview →